Institute

Back to overview
Name

Institut für Medizinische Virologie Universität Zürich

Address Institut für Medizinische Virologie Universität Zürich
Winterthurerstrasse 190
8057
CH-Zürich
Show all

Projects

Responsible applicant Institution of higher education Start End date Funding scheme

Structure and function of interferon receptors and inter- feron-induced proteins
Staeheli Peter University of Zurich - ZH 01.01.1988 30.09.1990 Project funding (Div. I-III)

T cell receptors and immunological network
Binz Hans University of Zurich - ZH 01.10.1982 30.09.1985 Project funding (Div. I-III)

The antiviral function of the interferon-induced Mx proteins
Pavlovic Jovan University of Zurich - ZH 01.04.1995 31.03.1998 Project funding (Div. I-III)

Messung der zellulären Immunität in vitro
Lindenmann Jean University of Zurich - ZH 01.04.1978 31.03.1979 Project funding (Div. I-III)

Rapid semirandom virus diagnostics using Nanopore amplicon sequencing
Huber Michael University of Zurich - ZH 01.02.2020 31.07.2022 Spark

Interferonbedingte, natürliche Resistenz gegen Orthomyxoviren.
Lindenmann Jean University of Zurich - ZH 01.04.1979 31.03.1981 Project funding (Div. I-III)

Application of an ultrasensitive PCR method, "Mega PCR" to the diagnosis of infectious agents present at extremely low concen- tration
Schüpbach Jörg University of Zurich - ZH 01.09.1997 31.12.2000 Project funding (Div. I-III)

Influenza A virus NS1 protein: molecular mechanisms of host-cell hijack
Hale Benjamin University of Zurich - ZH 01.09.2015 31.08.2018 Project funding (Div. I-III)

The antiviral activity of Mx proteins: Evaluation of the role of the cellular Mx-associated DExD/H-box RNA helicases UAP56 and URH49
Pavlovic Jovan University of Zurich - ZH 01.11.2012 31.03.2016 Project funding (Div. I-III)

Characterization of the nucleocapsid NC-protein of HIV-1
Mölling Karin University of Zurich - ZH 01.06.1994 31.12.1996 Project funding (special)

Transgenic mice carrying the resistance locus Mx
Lindenmann Jean University of Zurich - ZH 01.10.1986 30.09.1989 Project funding (Div. I-III)

Scanning Transmission and Computer Aided Volumic Electron Microscopy Application to Human Retroviruses
Bron Christophe R. University of Zurich - ZH 01.10.1993 31.12.1994 Project funding (Div. I-III)

Proteomic and Genetic Interrogation of the Human Interferon Response
Hale Benjamin University of Zurich - ZH 01.12.2018 30.11.2022 Project funding (Div. I-III)

Imprinting broadly neutralizing antibody responses to HIV-1
Trkola Alexandra University of Zurich - ZH 01.04.2021 31.03.2025 Project funding (special)

Untersuchungen über Autoimmunprozesse beim AIDS
Schüpbach Jörg University of Zurich - ZH 01.10.1986 31.03.1991 Project funding (Div. I-III)

Studies on the immunological network, on membrane proteins of invasive tumors and on human liver antigen F.
Binz Hans University of Zurich - ZH 01.10.1985 31.03.1987 Project funding (Div. I-III)

Identification of novel strain-specific dependency- and restriction factors of influenza A virus
Pohl-Puchstein Marie-Theres University of Zurich - ZH 01.03.2019 31.05.2019 Scientific Exchanges

Novel receptors for host cell entry of influenza A viruses
Stertz Silke University of Zurich - ZH 01.11.2021 31.10.2025 Project funding (Div. I-III)

Interactions of avian or porcine endogenous retroviruses with humans or human cells following enteral or parenteral exposure
Schüpbach Jörg University of Zurich - ZH 01.10.2000 31.12.2003 Project funding (Div. I-III)

Immunotherapy. Open label Phase I/II study (GMP)
Mölling Karin University of Zurich - ZH 01.01.2001 31.12.2001 NRP 37 Somatic Gene Therapy

Entry and reassortment potential of the newly discovered bat influenza A-like viruses
Stertz Silke University of Zurich - ZH 01.04.2016 30.04.2019 Project funding (Div. I-III)

Scanning Transmission and Computer Aided Volumic Electron Microscopy Application to Human Retroviruses
Bron Christophe R. University of Zurich - ZH 01.04.1990 30.09.1993 Project funding (Div. I-III)

Retroviren bei Tumor- und Autoimmunerkrankungen des Menschen
Schüpbach Jörg University of Zurich - ZH 01.04.1986 31.05.1992 Project funding (Div. I-III)

Attempt to eradicate lentivirus infection by activation of virus from host cells under the umbrella of anti-retroviral combinationtherapy.
Schüpbach Jörg University of Zurich - ZH 01.04.1998 30.06.2000 Project funding (Div. I-III)

Diagnostic and prognostic markers in pediatric HIV-1 infection
Schüpbach Jörg University of Zurich - ZH 01.07.1994 31.12.1996 Project funding (special)

Significance of a novel WD-propeller-FYVE protein for signalling
Mölling Karin University of Zurich - ZH 01.04.2007 31.12.2008 Project funding (Div. I-III)

Signalling of the Raf-kinase in complex biological systems
Mölling Karin University of Zurich - ZH 01.12.2000 31.03.2004 Project funding (Div. I-III)

Viral membrane glycoproteins: Intracellular transport and viral assembly studied by microinjection of antibodies and synthetic peptides
Arnheiter Heinz University of Zurich - ZH 01.10.1984 31.07.1986 Project funding (Div. I-III)

Nucleic acid based intervention of HIV replication
Mölling Karin University of Zurich - ZH 01.04.1997 31.05.2000 Project funding (special)

The influenza virus entry process - cell biological characterization and identification of novel drug targets
Stertz Silke University of Zurich - ZH 01.05.2011 31.10.2014 Project funding (Div. I-III)

The role of phosphorylation events during influenza A virus entry
Stertz Silke University of Zurich - ZH 01.11.2014 31.10.2017 Project funding (Div. I-III)

Study of the HIV-specific naïve B cell repertoire and Fc contribution of broadly neutralizing antibodies as tools for HIV-vaccine improvement
Bianchi Matteo University of Zurich - ZH 01.07.2018 31.03.2019 Return CH Advanced Postdoc.Mobility

Development of vectors for gene therapy
Mölling Karin University of Zurich - ZH 01.02.1997 30.09.2000 NRP 37 Somatic Gene Therapy

Isolation of c-Myb interacting proteins
Hovens Christopher Martin University of Zurich - ZH 01.10.1995 30.09.1998 Project funding (Div. I-III)

Non-proliferative signaling by negative regulation of the Raf kinase cascade
Mölling Karin University of Zurich - ZH 01.10.2004 30.09.2006 Project funding (Div. I-III)

The role of humoral immunity in HIV infection - Understanding broadly neutralizing antibody evolution
Trkola Alexandra University of Zurich - ZH 01.04.2014 31.03.2017 Project funding (special)

Analyse der Mil/Raf-Proteinkinase im Signalweg der Zelle
Mölling Karin University of Zurich - ZH 01.04.1994 31.03.1997 Project funding (Div. I-III)

Host proteins required for influenza virus entry as novel antiviral targets
Stertz Silke University of Zurich - ZH 01.11.2017 31.10.2021 Project funding (Div. I-III)

Identification and characterization of novel human retroviruses from diseases with suspected retroviral etiology ...
Böni Jürg Peter University of Zurich - ZH 01.07.1994 30.04.1997 Project funding (Div. I-III)

The multidomain protein CNK: a regulator of the Raf kinase pathway and integrator of signaling pathways
Radziwill Gerald University of Zurich - ZH 01.06.2004 31.05.2006 Project funding (Div. I-III)

Interferon-induced proteins and the antiviral state: The roles ofhuman and mouse Mx proteins
Pavlovic Jovan University of Zurich - ZH 01.10.1990 31.03.1995 Project funding (Div. I-III)

The role of the Raf kinase in normal and tumor cells during development and tumor formation
Mölling Karin University of Zurich - ZH 01.04.1997 30.11.2000 Project funding (Div. I-III)

Understanding HIV-1 broadly neutralizing antibody evolution - The Swiss 4.5K Screen
Trkola Alexandra University of Zurich - ZH 01.04.2017 31.03.2021 Project funding (special)
-